Preemptive and prophylactic ganciclovir therapy for CMV infection in heart transplant patients

By Paniagua M.J.   Crespo-Leiro M.G.   Rodriguez J.A.   Fojon S.   Zuniga M.C.   Canizares A.   Rey R.   Cuenca J.J.   Juffe A.   Castro-Beiras A.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2528-2529

Elsevier

Access to resources Recommend Favorite

CMV Infection and Allograft Rejection

By Hayry P.   Lemstrom K.   von Willebrand E.   Tikkanen J.   Koskinen P.  

Transplantation Proceedings, Vol. 30, Iss. 3, 1998-05 ,pp. : 916-917

Elsevier

Access to resources Recommend Favorite

Detection of CMV DNA in peripheral blood leukocytes as a long-range harbinger of CMV disease in HIV-infected patients

By Jaton Katia   Muheim Carmen   Barbani Maria-Teresa   Sahli Roland   Rudaz Patricia   Meylan Pascal R.A.  

Ocular Immunology and Inflammation, Vol. 7, Iss. 3-4, 1999-12 ,pp. : 147-157

Informa Healthcare

Access to resources Recommend Favorite

Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis

By Anglicheau D.   Lautrette A.   Scieux C.   Thervet E.   Martinez F.   Flamant M.   Morinet F.   Legendre C.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2826-2827

Elsevier

Access to resources Recommend Favorite

Reconstitution and Phenotype of Tregs in CMV Reactivating Patients Following Allogeneic Hematopoietic Stem Cell Transplantation

By Velaga Sarvari   Ukena Sya N.   Höpting Matthias   Ivanyi Philipp   Borchers Sylvia   Mischak-Weissinger Eva-Maria   Hamwi Iyas   Buchholz Stefanie   Ganser Arnold   Franzke Anke  

Immunological Investigations, Vol. 42, Iss. 1, 2013-01 ,pp. : 18-35

Informa Healthcare

Access to resources Recommend Favorite